Last 12 months
Inside the activity.
0 purchase rows · 169 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 23 |
| Dec 2025 | 0 | 18 |
| Jan 2026 | 0 | 44 |
| Feb 2026 | 0 | 22 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 10 |
| May 2026 | 0 | 19 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 220,564 | $50.00 | $11,028,200.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 14 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,481 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 220,564 shares sold at prices ranging from $50.00 to $50.08 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 32,156 | $17.07 | $548,902.92 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 12 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 358,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 20,111 | $26.43 | $531,533.73 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 10 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 323,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 39,446 | $26.46 | $1,043,741.16 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 8 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 299,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 25,046 | $34.03 | $852,315.38 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 6 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 256,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 27,074 | $24.70 | $668,727.80 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 4 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 29, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 76,731 | $28.88 | $2,215,991.28 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 197,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:46 UTC |
Wise John DraytonChief Commercial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · derivative · entry 4 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,250 shares Expires 2024-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:46 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 6,250 | $50.00 | $312,500.00 |
DisclosureSEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 3 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,657 F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:46 UTC |
Wise John DraytonChief Commercial Officer
|
Exercise / conversionCommon Stock | 6,250 | $12.58 | $78,625.00 |
DisclosureSEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:46 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 1,602 | $48.95 | $78,417.90 |
DisclosureSEC source: 0001628280-24-025895 · wk-form4_1717105566.xml · nonDerivative · entry 1 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,657 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,810 | $0.00 Strike: $13.67 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 11 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,810 shares Expires 2027-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,470 | $0.00 Strike: $11.38 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 10 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,470 shares Expires 2026-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,691 | $0.00 Strike: $10.85 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 9 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,691 shares Expires 2026-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $16.16 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 8 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $16.07 | $0.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · derivative · entry 7 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2025-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 44,722 | $49.53 | $2,215,080.66 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 6 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,828 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 14,810 | $13.67 | $202,452.70 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 133,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 3,470 | $11.38 | $39,488.60 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 3,691 | $10.85 | $40,047.35 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 10,000 | $16.16 | $161,600.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:45 UTC |
Smith Michael AlexanderChief Legal Officer
|
Exercise / conversionCommon Stock | 7,000 | $16.07 | $112,490.00 |
DisclosureSEC source: 0001628280-24-025894 · wk-form4_1717105507.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,579 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $12.58 | $0.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · derivative · entry 3 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,500 shares Expires 2024-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 27,500 | $49.53 | $1,362,075.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,760 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:44 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
Exercise / conversionCommon Stock | 27,500 | $12.58 | $345,950.00 |
DisclosureSEC source: 0001628280-24-025893 · wk-form4_1717105441.xml · nonDerivative · entry 1 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,260 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:43 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 103,806 | $0.00 Strike: $23.66 | $0.00 |
DisclosureSEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · derivative · entry 5 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,874 Underlying: Common Stock · 103,806 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:43 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 103,806 | $49.62 | $5,150,853.72 |
DisclosureSEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,134 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 103,806 shares sold at prices ranging from $49.53 to $50.00 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:43 UTC |
Flammer Martina M.D.Chief Medical Officer
|
Exercise / conversionCommon Stock | 103,806 | $23.66 | $2,456,049.96 |
DisclosureSEC source: 0001628280-24-025890 · wk-form4_1717105381.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 209,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 25 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,506 Underlying: Common Stock · 3,454 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $26.43 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 23 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,386 Underlying: Common Stock · 3,454 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 21 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,186 Underlying: Common Stock · 3,454 shares Expires 2031-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $34.03 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 19 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,146 Underlying: Common Stock · 3,454 shares Expires 2031-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options are exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Ms. Bonstein's continued employment with the Company on each vesting date. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $24.70 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 17 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,436 Underlying: Common Stock · 3,454 shares Expires 2030-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,454 | $0.00 Strike: $28.88 | $0.00 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · derivative · entry 15 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 88,186 Underlying: Common Stock · 3,454 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 20,724 | $50.01 | $1,036,407.24 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 13 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 338,045 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 20,724 shares sold at prices ranging from $50.00 to $50.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $17.07 | $58,959.78 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 11 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 326,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $26.43 | $91,289.22 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 9 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 303,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $26.46 | $91,392.84 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 7 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 260,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $34.03 | $117,539.62 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 5 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $24.70 | $85,313.80 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 3 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 28, 2024 Filed May 30, 2024 21:41 UTC |
Bonstein SaraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,454 | $28.88 | $99,751.52 |
DisclosureSEC source: 0001628280-24-025886 · wk-form4_1717105276.xml · nonDerivative · entry 1 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 17, 2024 Filed May 17, 2024 20:16 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 4,642 | $25.09 | $116,467.78 |
DisclosureSEC source: 0001628280-24-024066 · wk-form4_1715977000.xml · nonDerivative · entry 1 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,134 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 17, 2024 Filed May 17, 2024 20:15 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 5,945 | $25.09 | $149,160.05 |
DisclosureSEC source: 0001628280-24-024060 · wk-form4_1715976900.xml · nonDerivative · entry 1 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 149,275 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:39 UTC |
Wise John DraytonChief Commercial Officer
|
SaleCommon Stock | 5,088 | $25.47 | $129,591.36 |
DisclosureSEC source: 0001628280-24-023613 · wk-form4_1715805527.xml · nonDerivative · entry 2 Wise John Drayton · CIK 0001930805 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,259 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 5,088 shares sold at prices ranging from $25.45 to $25.50 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:37 UTC |
Smith Michael AlexanderChief Legal Officer
|
SaleCommon Stock | 5,093 | $25.40 | $129,362.20 |
DisclosureSEC source: 0001628280-24-023608 · wk-form4_1715805452.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,579 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 5,093 shares sold at prices ranging from $25.38 to $25.42 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:36 UTC |
Schaeffer Orlov S NicoleChief People Strategy Officer
|
SaleCommon Stock | 6,508 | $25.53 | $166,149.24 |
DisclosureSEC source: 0001628280-24-023605 · wk-form4_1715805404.xml · nonDerivative · entry 2 Schaeffer Orlov S Nicole · CIK 0001401017 · Chief People Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,760 F4 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F5 · price: This is the weighted average sales price representing 6,508 shares sold at prices ranging from $25.50 to $25.55 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:34 UTC |
Lewis WilliamDirector · Chair and CEO
|
SaleCommon Stock | 22,198 | $25.52 | $566,492.96 |
DisclosureSEC source: 0001628280-24-023600 · wk-form4_1715805282.xml · nonDerivative · entry 2 Lewis William · CIK 0001402051 · Director · Chair and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 384,125 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 22,198 shares sold at prices ranging from $25.41 to $25.67 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:33 UTC |
Flammer Martina M.D.Chief Medical Officer
|
SaleCommon Stock | 10,640 | $25.47 | $271,000.80 |
DisclosureSEC source: 0001628280-24-023598 · wk-form4_1715805215.xml · nonDerivative · entry 2 Flammer Martina M.D. · CIK 0001796960 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,776 F3 · shares: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 10,640 shares sold at prices ranging from $25.42 to $25.52 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:32 UTC |
Bonstein SaraChief Financial Officer
|
SaleCommon Stock | 11,088 | $25.32 | $280,748.16 |
DisclosureSEC source: 0001628280-24-023591 · wk-form4_1715805145.xml · nonDerivative · entry 2 Bonstein Sara · CIK 0001604019 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,481 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 11,088 shares sold at prices ranging from $25.28 to $25.36 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:31 UTC |
Adsett RogerChief Operating Officer
|
SaleCommon Stock | 7,857 | $25.50 | $200,353.50 |
DisclosureSEC source: 0001628280-24-023589 · wk-form4_1715805079.xml · nonDerivative · entry 2 Adsett Roger · CIK 0001685904 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,220 F3 · kind: Shares sold to satisfy withholding tax obligations upon the vesting of RSUs and to cover related broker fees. F4 · price: This is the weighted average sales price representing 7,857 shares sold at prices ranging from $25.48 to $25.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.